Tool
Supplement comparison tool
Pick up to 4 knowledge base entries and compare their dosage, price, evidence strength and ratings side by side — you can save or share a link to your selection.
Add to comparison (2/4)
| Category | Leki | Leki |
| Evidence strength | Strong evidence | Strong evidence |
| Evidence Score | 5/5 | 5/5 |
| User rating | 4.3 (87) | 4.5 (58) |
| Typical dose | Depends on the indication and specific drug — usually 20–40 mg once daily, for the shortest time possible for the given indication | Start at 2.5 mg weekly, gradual escalation every 4 weeks to a maintenance dose of 5, 7.5, 10, 12.5, or a maximum of 15 mg weekly, depending on tolerance and treatment goal |
| Form | Oral tablets or capsules | Solution for subcutaneous injection in a single-use autoinjector (Mounjaro, Zepbound) |
| Average price | — | ok. 1000–1600 zł za opakowanie miesięczne, zależnie od dawki i apteki |
| Monthly cost | — | ok. 1000–1600 zł/miesiąc |
| Time to effects | Significant symptom reduction usually within a few days, full therapeutic effect after 1–4 weeks of regular use. | Reduced appetite is sometimes noticeable within the first few weeks, but meaningful, measurable weight loss develops gradually over several months, and the full effect assessed in SURMOUNT-1 was measured after 72 weeks (about 1.5 years) of regular treatment. |
| Who it's for | People with gastroesophageal reflux disease or stomach/duodenal ulcers | People with type 2 diabetes with inadequate glycemic control on other oral medications |